Brain PET-MRI Systems Market Trends

Growth drivers

• Improvement in diagnostic results: The hybrid of MRI and PET is efficiently enhancing the quality of imaging facilities in healthcare sectors. According to a research report published by JNM (The Journal of Nuclear Medicine) in August 2020, the PET-MRI system can deliver improved lesion detection in selected cancers, promoting fast, efficient local and whole-body staging in one step. Besides, it can potentially benefit younger patients, by reducing radiation exposure. This two-in-one imaging system is 50% more efficient than a PET/CT in detecting abnormal findings in the Brain, which are useful in treating Alzheimer’s, epilepsy, and brain tumors. Based on their usefulness and diverse service range, many doctors are now recommending PET/MRI, further stimulating remarkable growth in demand.
• Governmental association and investment: Government healthcare authorities are investing in new and improved diagnostic systems in medical facilities. In October 2023, Novo Nordisk Foundation offered a grant of DKK 17 million to the researchers from the Faculty of Health and Medical Sciences at the University of Southern Denmark (SDU). the grant is aimed at acquiring a new simultaneous preclinical PET/MRI scanner, escalating their research and treatment facility. In November 2022, the Ireland government announced funding of USD 44.7 million under the DTIF (Disruptive Technologies Innovation Fund) for 11 projects across health and wellbeing, advanced robotics, and machine learning. Such involvement of governing bodies in individual regional brain PET-MRI market is manifesting noteworthy growth.
• Inflated demand for non-invasive diagnosis: There has been a noticeable increment in the requirement for non-invasive diagnosis, majorly since the COVID-19 pandemic, indicating the scope of growth in the brain PET-MRI systems market. The surge is inspiring leading companies to contribute to innovations in the diagnostic sector. The next-generation multimodality function of PET-MRI systems is perfectly aligned with this investment plan. The complete analysis provides complementary data, which helps doctors determine the root cause and stage of the neurological diseases.

Challenges

• Strignenet regulations: The regulatory approval from medical authorities and governing bodies is the major setback in the process of PET-MRI systems production. The evaluation process of functionality and patient safety can make the process elongated, further restraining fast growth. The regulations for medical devices are non-flexible with respect to regional markets, which creates uncertainty in distribution.
• Impact on performance during development: PET systems with photomultiplier tubes (PMTs) are extremely sensitive to high magnetic fields, which creates attenuation maps for PET images, further impacting the effectiveness of the device. This developmental restriction can cause a decline in the future growth of the brain PET-MRI systems market.